Tuberculosis, Extrapulmonary
Tuberculosis, Extrapulmonary
Explore linked clinical trials. Standard reference: MESH:M00075159517 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| B-PaLMZ for TB Meningitis | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, Infections, Neuroinflammatory Diseases, Tuberculosis, Central Nervous System, Tuberculosis, Extrapulmonary, bacterial infectious disease, bacterial meningitis, central nervous system disorder, central nervous system infectious disorder, disease arising from reactivation of latent virus, gram-positive bacterial infections, latent tuberculosis infection, meningeal tuberculosis, meningitis, mycobacterial infectious disease, nervous system disorder, tuberculosis | Recruiting | Phase 2 | 2026-09-30 | NCT07227779 | |
| Diagnostic Utility of Mycobacterium Tuberculosis Cell-free DNA in Hong Kong | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Infections, Tuberculosis, Extrapulmonary, bacterial infectious disease, gram-positive bacterial infections, mycobacterial infectious disease, pleural disorder, pleural tuberculosis, respiratory system disorder, respiratory tract infectious disorder, tuberculosis | Recruiting | Not stated | 2026-09-03 | NCT06646237 | |
| MBLA to Differentiate IRIS From Treatment Failure in Extrapulmonary Tuberculosis | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Hemic and Lymphatic Diseases, Infections, Lymphadenopathy, Tuberculosis, Extrapulmonary, bacterial infectious disease, gram-positive bacterial infections, lymphatic system disorder, mycobacterial infectious disease, tuberculosis | Not yet recruiting | Not stated | 2026-08-31 | NCT07778082 | |
| Shortened Regimen for Drug-susceptible TB in Children | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Infections, Tuberculosis, Extrapulmonary, bacterial infectious disease, gram-positive bacterial infections, lung disorder, lymph node tuberculosis, mycobacterial infectious disease, pulmonary tuberculosis, respiratory system disorder, respiratory tract infectious disorder, tuberculosis | Recruiting | Phase 3 | 2026-07-24 | NCT06253715 | |
| Tuberculosis Clinical Registry in Europe | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Infections, Tuberculosis, Extrapulmonary, bacterial infectious disease, gram-positive bacterial infections, mycobacterial infectious disease, tuberculosis | Not yet recruiting | Not stated | 2026-07-01 | NCT07677904 | |
| Intensified Tuberculosis Treatment to Reduce the Mortality of Patients With Tuberculous Meningitis | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, Infections, Neuroinflammatory Diseases, Tuberculosis, Central Nervous System, Tuberculosis, Extrapulmonary, bacterial infectious disease, bacterial meningitis, central nervous system disorder, central nervous system infectious disorder, gram-positive bacterial infections, meningeal tuberculosis, meningitis, mycobacterial infectious disease, nervous system disorder, tuberculosis | Recruiting | Phase 3 | 2026-06-24 | NCT04145258 | |
| Trial of a Six-Month Regimen of High-Dose Rifampicin, High-Dose Isoniazid, Linezolid, and Pyrazinamide Versus a Standard Nine-Month Regimen for the Treatment of Adults and Adolescents With Tuberculous Meningitis | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, Infections, Neuroinflammatory Diseases, Tuberculosis, Central Nervous System, Tuberculosis, Extrapulmonary, bacterial infectious disease, bacterial meningitis, central nervous system disorder, central nervous system infectious disorder, gram-positive bacterial infections, meningeal tuberculosis, meningitis, mycobacterial infectious disease, nervous system disorder, tuberculosis | Recruiting | Phase 2 | 2026-06-02 | NCT05383742 | |
| Adjunctive Doxycycline for Central Nervous System Tuberculosis | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, Infections, Neuroinflammatory Diseases, Tuberculosis, Central Nervous System, Tuberculosis, Extrapulmonary, bacterial infectious disease, bacterial meningitis, brain disorder, central nervous system disorder, central nervous system infectious disorder, encephalitis, gram-positive bacterial infections, meningeal tuberculosis, meningitis, meningoencephalitis, mycobacterial infectious disease, nervous system disorder, tuberculosis, viral infection of central nervous system | Recruiting | Phase 2 | 2026-06-01 | NCT06446245 | |
| Blood Tuberculosis DNA Levels to Monitor Tuberculosis Treatment | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Infections, Tuberculosis, Extrapulmonary, bacterial infectious disease, gram-positive bacterial infections, lung disorder, mycobacterial infectious disease, pulmonary tuberculosis, respiratory system disorder, respiratory tract infectious disorder, tuberculosis | Recruiting | Not stated | 2026-04-13 | NCT06845618 | |
| Diagnostic Utility of Mycobacterium Tuberculosis Cell-free DNA | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Infections, Tuberculosis, Extrapulmonary, bacterial infectious disease, gram-positive bacterial infections, mycobacterial infectious disease, pleural disorder, pleural tuberculosis, respiratory system disorder, respiratory tract infectious disorder, tuberculosis | Recruiting | Not stated | 2026-03-31 | NCT06439810 | |
| Phase 2a Trial of Alpibectir Plus Ethionamide for Tuberculosis Meningitis | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, Infections, Neuroinflammatory Diseases, Tuberculosis, Central Nervous System, Tuberculosis, Extrapulmonary, bacterial infectious disease, bacterial meningitis, central nervous system disorder, central nervous system infectious disorder, gram-positive bacterial infections, meningeal tuberculosis, meningitis, mycobacterial infectious disease, nervous system disorder, tuberculosis | Not yet recruiting | Phase 2 | 2026-03-03 | NCT07350174 | |
| Tnf Inhibitors to Reduce Mortality in HIV-1 Infected PAtients With Tuberculosis meNIngitis | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, Infections, Neuroinflammatory Diseases, Tuberculosis, Central Nervous System, Tuberculosis, Extrapulmonary, bacterial infectious disease, bacterial meningitis, central nervous system disorder, central nervous system infectious disorder, gram-positive bacterial infections, meningeal tuberculosis, meningitis, mycobacterial infectious disease, nervous system disorder, tuberculosis | Recruiting | Phase 2 | 2025-12-15 | NCT05590455 | |
| Study About Drug Resistance of Mycobacterium Tuberculosis | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Infections, Tuberculosis, Extrapulmonary, bacterial infectious disease, gram-positive bacterial infections, mycobacterial infectious disease, tuberculosis | Not yet recruiting | Not stated | 2025-09-11 | NCT07169149 | |
| A Multicentric Cohort and Biomarker Study for Improved Care of Patients with Extrapulmonary Tuberculosis | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Infections, Tuberculosis, Extrapulmonary, bacterial infectious disease, gram-positive bacterial infections, mycobacterial infectious disease, tuberculosis | Recruiting | Not stated | 2025-03-13 | NCT06875336 | |
| Phase II Clinical Study of Contezolid for the Treatment of Tuberculous Meningitis | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, Infections, Neuroinflammatory Diseases, Tuberculosis, Central Nervous System, Tuberculosis, Extrapulmonary, bacterial infectious disease, bacterial meningitis, central nervous system disorder, central nervous system infectious disorder, gram-positive bacterial infections, meningeal tuberculosis, meningitis, mycobacterial infectious disease, nervous system disorder, tuberculosis | Enrolling by invitation | Phase 1 / Phase 2 | 2025-02-06 | NCT06811025 | |
| Gene Expression Profiles in Spinal Tuberculosis. | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Bone Diseases, Infectious, Discitis, Infections, Tuberculosis, Extrapulmonary, bacterial infectious disease, bone disorder, gram-positive bacterial infections, musculoskeletal system disorder, mycobacterial infectious disease, skeletal tuberculosis, spondylitis, tuberculosis, tuberculosis, spinal, vertebral column disorder | Recruiting | Not stated | 2024-08-23 | NCT05610098 | |
| Intensified Short Course Regimen for TBM in Adults | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, Infections, Neuroinflammatory Diseases, Tuberculosis, Central Nervous System, Tuberculosis, Extrapulmonary, bacterial infectious disease, bacterial meningitis, central nervous system disorder, central nervous system infectious disorder, gram-positive bacterial infections, meningeal tuberculosis, meningitis, mycobacterial infectious disease, nervous system disorder, tuberculosis | Not yet recruiting | Phase 3 | 2023-12-21 | NCT05917340 |